Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
3
×
life sciences
national blog main
new york blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
deals
fda
investing
national top stories
new york top stories
pfizer
startups
4d molecular therapeutics
abbvie
achaogen
acne
adams street partners
agenus
akcea therapeutics
antibiotics
anylam pharmaceuticals
astrazeneca
auris health
avexis
bayer
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
What
disease
3
×
drug
3
×
approved
fda
medicines
year
ago
akcea
alnylam
amyloidosis
attr
available
bacteria
battle
bio
biopharma
business
companies
company
debilitating
digital
epidemic
exited
fatty
fighting
frenzied
genetic
growing
infections
infectious
known
launches
led
liver
melinta
merck
nash
news
oks
patients
Language
Current search:
drug
×
drugs
×
disease
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections